Neogen Chemicals Raises ₹600 Crore Via QIP at ₹2,255/Share
Neogen Chemicals successfully raised ₹599.99 crore through a QIP by issuing 26,60,753 equity shares at ₹2,255 per share. The issue, which closed on September 16, 2026, saw significant participation from institutional investors.
The QIP is a significant fundraising event that increases the company's equity base and provides substantial capital, which can have a material impact on its future operations, expansion plans, and financial leverage.
The company successfully raised a substantial amount of capital through a QIP, which is generally viewed positively as it strengthens the company's financial position and provides funds for growth.
Neogen Chemicals Limited has announced the successful completion of its Qualified Institutions Placement (QIP), raising approximately ₹599.99 crore (₹5,99,99,98,015.00). The Fund-Raising Committee of the company approved the issue and allotment of 26,60,753 equity shares at an issue price of ₹2,255 per equity share, including a premium of ₹2,245 per share. This price is higher than the determined floor price of ₹2,189.73.
The QIP issue opened on September 10, 2026, and closed on September 16, 2026. Following the allotment of these shares, the company's paid-up equity share capital has increased from ₹27.38 crore to ₹30.04 crore, with the total number of equity shares rising to 3,00,42,427 equity shares of ₹10 each.
The newly allotted equity shares will be listed on both the BSE Limited and the National Stock Exchange of India Limited, ranking pari passu with the existing equity shares in all respects, including dividends and voting rights. The announcement also details the significant allottees who have acquired more than 5% of the equity shares offered in the QIP, including entities like ICICI Prudential Commodities Fund, Invesco India Small Cap Fund, Mirae Asset Aggressive Hybrid Fund, SBI Life Insurance Co. Ltd, WhiteOak Capital Flexi Cap Fund, Axis Mutual Fund Trustee Limited, and Abu Dhabi Investment Authority.
What to do with a filing like this
Neogen Chemicals Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Neogen Chemicals Limited. Read the original for the full detail.